DFDA

Mitral Valve Repair (Surgical)

Treatment for Non Rheumatic Degenerative Mitral Valve Disease

Effectiveness
90%
Safety Score
55%
Clinical Trials
1,500
Participants
500K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate symptom relief post-recovery (full recovery 3-6 months)
Treatment Duration
One-time procedure
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$500
Total Annual:$2,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$35,000/QALY
QALYs Gained
4.5
Outcome-Based Costs
Cost per Responder
$2,105.26
Cost per Remission
$2,222.22
Comparison vs Mitral Valve Replacement
Cost Difference
$-10,000/year
Less expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Mitral Valve Repair (Surgical) Outcomes

for Non Rheumatic Degenerative Mitral Valve Disease

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Arrhythmias (e.g., Atrial Fibrillation)
+30%
Bleeding/Transfusion
+10%
Stroke
+2%
Infection
+3%
Acute Kidney Injury
+7%
In-hospital Mortality
+2%

Sources:

nih.gov
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov